Showing results (641-650 of 1,995) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|March 20, 2009
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trialHeleen M den Hertog, H Bart van der Worp, H Maarten A van Gemert, et al.The Lancet. Neurology|June 13, 2009
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trialDag Aarsland, Clive Ballard, Zuzana Walker, et al.The Lancet. Neurology|June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort studyPieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.The Lancet. Neurology|October 14, 2008
Clinical features, pathogenesis, and treatment of Guillain-Barré syndromePieter A van Doorn, Liselotte Ruts, Bart C JacobsThe Lancet. Neurology|February 24, 2009
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic reviewValery L Feigin, Carlene M M Lawes, Derrick A Bennett, et al.The Lancet. Neurology|December 17, 2008
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodologyAlexis Arzimanoglou, Jacqueline French, Warren T Blume, et al.The Lancet. Neurology|September 29, 2009
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control studyRolf T Urbanus, Bob Siegerink, Mark Roest, et al.The Lancet. Neurology|April 7, 2009
Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening studyAna Djarmati, Susanne A Schneider, Katja Lohmann, et al.Pageof 200